Over de innovatie
Making it easy to store your medication correctly while traveling, enhances therapy compliance and reduces the spoiling of expensive medication. This is one of the simplest ways to control medication costs. Using medication in the prescribed way, will increase health results, therapy compliance and improve vitality of all these people.
Currently, patients rely mostly on cooling bags filled with ice-packs from the freezer.
The problem with these bags is that they give no more than 6-8 hours of safe travel time. There is no temperature monitoring, therefore the patients are in constant stress and insecurities because they don't know the temperature of their medication. In addition, by using ice-packs from the freezer there is a chance the medication freezes. If this happens the medication becomes useless and needs to be replaced. With the cooling bags, patients remain dependent on fridges and freezers whilst traveling.
Our goal is to give back freedom and security to people who depend on temperature-sensitive medication and travel with their medication.
The Cool-One is a lightweight (2.3 kg) portable cooler capable of preserving its inside temperature (2-8°C) for 24 hours, without the utilization of electrical power. It can store on average 6 weeks of medication. It measures real-time the inside temperature, to provide the much-needed security about the medication to the user. The cooler can be recharged by connecting it to a power source, allowing patients to travel without relying on fridges and freezers.
< 2.3 kg
Stores on average 6 weeks of medication
Electrically rechargeable in 2 hours
Can be taken on an airplane as hand luggage
Monitoring of inside temperature
Does not look like a medical device, so less stigmatization
Our patented technology guarantees a temperature between 2 - 8 degrees for a minimum of 24 hours, with an ambient temperature of 25 degrees Celsius. Using a combination of isolation and heat-transfer materials, we made sure the temperature is the same in the entire inner system.
During the 24 hour travel time, patients are independent of electricity.
The cooler can be recharged by connecting it to a power source. the cooler is fully recharged within 2 hours. During the charging of the cooler the medication can stay inside. This way the patient is not dependent on fridges or freezers whilst traveling, allowing for more freedom.
The Cool-One can carry on average 6 weeks of medication. 85% of all injection-pens and ampules manufactured to use these kind of medication. Most of this group of medication is what is called biologics.
A display and a mobile application shows the real-time temperature to create the much needed security to the user.
None of the competitors can guarantee > 24 hours of travel-time, with temperature display and an electrically recharging feature.
One competitor, called lifeinabox, has the potential to be the biggest competitor of Meds2Go. This is a French based company that builds mini-fridges. They show the real-time temperature and can carry the same amount of medication and weighs the same. However, it is more electrically dependent. Where we allow a 24 hour travel time, the lifeinabox has 8 hours of travel time.
The three main target groups can be divided by people with rheumatism arthritis, multiple sclerosis (MS) and growth hormone deficiency (GHD). Our focus customer can be man, woman and (parents of) children of all ages. People suffering from rheumatism arthritis using biologics are by far the largest group of users, being 35% of the total group.
Besides the three main groups, there are around 20 more diseases that use biologics, like Crohn's disease, hepatitis, acromegaly, coagulation disorders, cancer and fertility disorders etc.
Meds2Go focus is on temperature-sensitive medication/ biologics. Our research shows a potential market of 130.000 people in the Netherlands. On a European level that equals to 3.8 million individual users. The market is expected to grow in the coming decades. In the Netherlands, more than 6.000 people are prescribed biologicals for the first time.
Meds2Go will use multiple sales channels, firstly through it's own Webshop.
The consumer price of the Cool-One will be € 350 (incl. VAT).
Meds2Go is looking for partners with medical channels like home-care stores or (online) pharmacies. There is a margin reserved for distribution channels.
Next to the Cool-One, Meds²Go will sell add-on products like: carrier bags and recharge devices.
2018 Dutch Patent filed
2019 filed patent to European market
(“indienen van een Europese octrooiaanvraag met inroeping van de
prioriteit van Nederlandse octrooiaanvragen”)
2020 filed patent application at USPTO (USA) with reference being given to Dutch
2020 Dutch Patent filed
Our (Dutch) patent(s) consist of the combination of (insulation) parts of our container and add-on features.
Trademark registered for the BeNeLux
2018/2020 filed for Design rights (Dutch “Modellenrecht”) Cool One
2019 Design rights extended to European Market
Technical testing consisted of exposing the prototypes to different temperatures and measure the cooling and insulation performance. The results were compared to our computer simulations to further improve the strength of our computer simulation models. With these results, we can better predict the performance of future designs.
16 of them were women. The age of the testers varied between 18 - 64
Of the 18 testers, there were 9 different types of disease and 14 types of medication
Technical testing in climate chambers confirmed our claims for 24 hours at an ambient temperature of 25°C. Even at a constant ambient temperature of 35 °C the cooler maintains the 2-8°C range for 17.5 hours.
Testers do want more information on the display. For the prototype we displayed: LOW if the temperature became under 2 degrees and HIGH when it became above 8 degrees. Patients want to know exactly how high or low, so they can make their own decisions.
The opening has to give more grip, so people can use there hole hand to open it, which is important for people who have weakening of muscles of pain (like rheuma or MS).
Meds²Go will make a different strap, so it is easier to carry and people have a choice to carry it around there shoulders. These results were integrated in the final product.
We have adjusted and optimized our sales strategy according to this Black Swan event.
We noticed a trend where longer vacations are replaced for shorter & more frequent trips.
Meds²Go works hard on sales and making deals with the right distributors.
The challenge for the technical team is to optimize the built of materials to minimize the cost prize.
Meds2Go started with a Pre-Sales campaign in October 2020 ending November 2020.
to test the final product and get a better understanding of the willingness-to-pay of our customers. During the Pre-Sales, we reached our goal by selling >100 units.
The pre-sales campaign gave more insights into our paying customer,
Carla van den Bos - Founder & chair of the board
Ad Linssen - MD & CFO
Ronald Nanninga - CTO
Hans Jakop Burkens - Commercial Director
Steven Gijselman - Business Developer
Michiel de Bie - Product Developer
Dirkjan Hupkes - Reputation Engineer
Folco Blanker - jr Product Developer
Lennard van der Giessen - jr Business Developer
Meds²Go works with external partners in product development and marketing.
In 2021 Meds²Go intends to hire people for the marketing & sales-team and tech team
After Meds²Go put it's first product on the market, we will continue to develop solutions in the last mile of the cold chain. For this we need to increase our tech-team.
We are highly motivated to solve problems for (chronic) patients and improve their quality of life. This combination allows us to come up with innovative ideas and products for healthcare which we are we are also able to bring to the market.
Meds2Go already started implementation by starting a pre-sales campaign.
With the pre-sales we allow early adaptors to buy the product. From then on these early adopters have to be our ambassadors. Our cooler is more expensive than ordinary cooling bags. Therefore, the recommendations of patients are very important to convince new buyers.
Our product offers more security safety and a longer cooling time, therefore we will position the Cool-One as a high-end product. This product might not be affordable for every patient, to compensate Meds2Go will offer discount until the product launch and offer options to pay in installments. After successful launch of the Cool-One, we will continue the development of cold-chain solutions to offer cheaper versions of the Cool-One.
Meds²Go will start sales within the group of patients who have the biggest pain, being the daily users of temperature-sensitive medication.
We are in contact with patient organizations where these patients spend a lot of time and can be reached. Also Meds2Go has invested time and money to built a community of cooled medication users.
Next to direct sales, Meds²Go will use existing distribution channels that already reach our end-user, like home-care stores and pharmacist.
The message we want to send is the importance of correctly storing temperature sensitive medication. That patients should have the freedom & security to travel despite their medication. That with our cooler they no longer are dependent on fridges or freezers.
Finalist European women startup challenge in Paris 2019
Finalist startup funding event 2019
Winner Good Industrial Design award 2019
Successfully completed a pre-sales campaign 2020
Meds2Go will continue developing new versions of the Cool-One with different specs. For example a cooler without the ability to recharge electrically or one that cools longer or less than 24 hours. With different versions, the customer can choose the best cooler suited to their specific needs.
With the technique and credibility of the Cool-One we will develop larger coolers that are suited for the vaccination market and the cold-chain transportation market.
We expect to have completed fully functional prototypes in Q1-2021.
For Meds2Go Cold Chain B.V. we expect working prototypes in Q1-2021. These prototypes will be tested and shown to potential customers who are operating in cold chain delivery. Potential customers are a online pharmacy warehouse located in the United States and (online) pharmacies located in the Netherlands.
One of the distribution channels Meds2Go is looking in is Amazon. With a international reach and a low distribution margin this channel might become relevant for Meds2Go.
Furthermore, we are looking for online pharmacies with an international market to use as a distribution partner for the Cool-One or for the larger Cold-Chain coolers.